We conducted a case-control study in China to clarify the association between XRCC1-Arg399Glnpolymorphism and HCC risk. A total of 150 cases and 158 controls were selected from the the Affiliated Hospitalof Qingdao University from May 2008 to May 2010. XRCC1-Arg399Gln polymorphism was based upon duplexpolymerase-chain-reaction with the confronting-two-pairprimer (PCR-CTPP) method. All analyses wereperformed using the STATA statistical package. A significantly increased risk was associated with the Arg/Glngenotype (adjusted OR 1.78, 95%CI=1.13-2.79) compared with genotype Arg/Arg. In contrast, the Gln/Glngenotype had non-significant increased risk of HCC with adjusted OR (95%CI) of 1.69 (0.93-2.66). A significantassociation was found between positive HBsAg and Arg/Gln, with an OR of 3.43 (95% CI=1.45-8.13). Patientscarrying Gln/Gln genotypes showed significantly lower median survival than Arg/Arg genotypes (HR=1.38,95% CI=1.04-1.84). Further Kaplan-Meier analysis showed decreased median survival in Arg/Gln+Gln/Glngenotype carriers in comparison to Arg/Arg carriers (HR=1.33, 95% CI=1.02-1.76). In conclusion, we observedthat XRCC1-Arg399Cln polymorphism is associated with susceptibility to HCC, and XRCC1 Gln allele genotypeshowed significant prognostic associations.
(2012). Evaluation of DNA Repair Gene XRCC1 Polymorphism in Prediction and Prognosis of Hepatocellular Carcinoma Risk. Asian Pacific Journal of Cancer Prevention, 13(1), 191-194.
MLA
. "Evaluation of DNA Repair Gene XRCC1 Polymorphism in Prediction and Prognosis of Hepatocellular Carcinoma Risk". Asian Pacific Journal of Cancer Prevention, 13, 1, 2012, 191-194.
HARVARD
(2012). 'Evaluation of DNA Repair Gene XRCC1 Polymorphism in Prediction and Prognosis of Hepatocellular Carcinoma Risk', Asian Pacific Journal of Cancer Prevention, 13(1), pp. 191-194.
VANCOUVER
Evaluation of DNA Repair Gene XRCC1 Polymorphism in Prediction and Prognosis of Hepatocellular Carcinoma Risk. Asian Pacific Journal of Cancer Prevention, 2012; 13(1): 191-194.